The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
This preconference is a unique Pharmacology program intended for both general practice or specialty clinicians who care for patients with heart failure including practitioners, clinical nurse specialists, registered nurses and other providers interested in pharmacologic management…
Learning Objectives
Describe the epidemiology and pathophysiological connection between heart failure and
amyloid.
Highlight the mechanism of action, pharmacokinetics, side effects, contraindications, and monitoring parameters for the new approved medications for amyloid.
Using evidenced based data, discuss the role medications have in the management of patients with heart failure and amyloid.